These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1897329)

  • 1. Circulating levels of calciotropic hormones during treatment with nasal salmon calcitonin.
    Thamsborg G; Storm TL; Daugaard H; Schifter S; Sørensen OH
    Acta Endocrinol (Copenh); 1991 Aug; 125(2):127-31. PubMed ID: 1897329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
    Chesnut CH; Silverman S; Andriano K; Genant H; Gimona A; Harris S; Kiel D; LeBoff M; Maricic M; Miller P; Moniz C; Peacock M; Richardson P; Watts N; Baylink D
    Am J Med; 2000 Sep; 109(4):267-76. PubMed ID: 10996576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
    Tankó LB; Bagger YZ; Alexandersen P; Devogelaer JP; Reginster JY; Chick R; Olson M; Benmammar H; Mindeholm L; Azria M; Christiansen C
    J Bone Miner Res; 2004 Sep; 19(9):1531-8. PubMed ID: 15312255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of different doses of nasal salmon calcitonin on plasma cyclic AMP and serum ionized calcium.
    Thamsborg G; Storm TL; Brinch E; Sykulski R; Fogh-Andersen N; Holmegaard SN; Sørensen OH
    Calcif Tissue Int; 1990 Jan; 46(1):5-8. PubMed ID: 2153040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calciotropic hormones and markers of bone remodeling in age-related (type II) femoral neck osteoporosis: alterations consistent with secondary hyperparathyroidism-induced bone resorption.
    Boonen S; Broos P; Verbeke G; Aerssens J; Van Herck E; Jans I; Dequeker J; Bouillon R
    J Gerontol A Biol Sci Med Sci; 1997 Sep; 52(5):M286-93. PubMed ID: 9310082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineral homeostasis during lactation- relationship to serum 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, parathyroid hormone and calcitonin.
    Greer FR; Tsang RC; Searcy JE; Levin RS; Steichen JJ
    Am J Clin Nutr; 1982 Sep; 36(3):431-7. PubMed ID: 6896793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of nicotine on bone and calciotropic hormones in adult female rats.
    Fung YK; Iwaniec U; Cullen DM; Akhter MP; Haven MC; Timmins P
    Pharmacol Toxicol; 1999 Oct; 85(4):181-7. PubMed ID: 10563517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum parathyroid hormone, calcitonin, and 1,25-dihydroxyvitamin D in lactating women nursing twins.
    Greer FR; Lane J; Ho M
    Am J Clin Nutr; 1984 Sep; 40(3):562-8. PubMed ID: 6548076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early effect of nasal salmon calcitonin on the bone marker Crosslaps.
    Ofluoglu D; Karadag-Saygi E; Canbulat C; Gunduz OH; Kul-Panza E; Akyuz G
    Rheumatol Int; 2006 Feb; 26(4):288-91. PubMed ID: 15875189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of nasal salmon calcitonin on cell-mediated immunity.
    Thamsborg G; Møller T; Kollerup G; Sørensen OH
    Bone Miner; 1993 Mar; 20(3):245-9. PubMed ID: 8490328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
    Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
    Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calciotropic hormones in rheumatology].
    Cormier C; Souberbielle JC; Kindermans C
    Ann Biol Clin (Paris); 1997; 55(4):311-8. PubMed ID: 9309229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nifedipine, but not verapamil, acutely elevates parathyroid hormone levels in premenopausal women.
    Wynne AG; Romanski SA; Klee GG; Ory SJ; O'Fallon WM; Fitzpatrick LA
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):9-15. PubMed ID: 7889637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of calcium-regulating hormones by exogenous sex steroids in early postmenopause.
    Stevenson JC; Abeyasekera G; Hillyard CJ; Phang KG; MacIntyre I; Campbell S; Lane G; Townsend PT; Young O; Whitehead MI
    Eur J Clin Invest; 1983 Dec; 13(6):481-7. PubMed ID: 6315447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and progestin effects on urinary calcium and calciotropic hormones in surgically-induced postmenopausal women.
    Lobo RA; Roy S; Shoupe D; Endres DB; Adams JS; Rude RK; Singer FR
    Horm Metab Res; 1985 Jul; 17(7):370-3. PubMed ID: 3161813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of salmon calcitonin nasal spray treatment in postmenopausal women after total hip arthroplasty.
    Peichl P; Griesmacher A; Kumpan W; Schedl R; Prosquil E; Bröll H
    Gerontology; 2005; 51(4):242-52. PubMed ID: 15980653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin mRNA expression and plasma calciotropic hormones in fetal lambs.
    Collignon H; Davicco MJ; Barlet JP
    Domest Anim Endocrinol; 1996 May; 13(3):269-76. PubMed ID: 8738868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial.
    Binkley N; Bolognese M; Sidorowicz-Bialynicka A; Vally T; Trout R; Miller C; Buben CE; Gilligan JP; Krause DS;
    J Bone Miner Res; 2012 Aug; 27(8):1821-9. PubMed ID: 22437792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.
    Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
    N Engl J Med; 1993 Jun; 328(24):1747-52. PubMed ID: 7684512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.